Truist Financial, Leerink partners, and Morgan Stanley have raised price targets and weighed in on Incyte stock.

The entities involved

• Incyte →

  American pharmaceutical company

  • Incyte, a biotech company based in Wilmington, outperformed the biotech ETF.Thu 13:11
• Truist Financial →

  American bank holding company, formerly known as BB&T Corporation

  • MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.Mon 13:11
  • Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.Mon 11:04
• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Related events

• TD Cowen upgraded shares of Incyte to strong-buy rating and adjusted price targets on August 25, 2026.Aug 25
• Truist Financial and Leerink Partners raised price objectives for Eli Lilly and Company stock.Sep 2
• Citigroup and Truist Financial issued buy ratings and increased price targets for Cisco.Aug 27
• Bank of America and Morgan Stanley raised price targets for Agilent Technologies stock.Sep 9
• Morgan Stanley adjusted its target price for Global-e Online, and Truist Financial also raised its target price for the company.Aug 28